Search research articles
Contact Us
Filters
Showing results (1-10 of 110) with videos related to
Page
of 11
Sort By:
Cell Cycle (Georgetown, Tex.)
|
May 22, 2004
hTert-immortalized endothelial cells: an important new research tool
Douglas K Price, William D Figg
Cancer Biology & Therapy
|
July 16, 2004
Mutations in the EGFR: the importance of genotyping
Douglas K Price, William D Figg
Cancer Biology & Therapy
|
July 10, 2014
Prostate tumor development and androgen receptor function alterations in a new mouse model with ERG overexpression and PTEN inactivation
Anjali Srivastava, Douglas K Price, William D Figg
Anti-Cancer Drugs
|
April 7, 2007
ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer
Haiqing Li, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
May 6, 2016
YAP controls transcriptional elongation through CKD9 recruitment for proximal pause release: "Hippo-thetical", new therapeutic targets?
Fiorina Kyritsi, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
December 19, 2006
DNA microarrays: tissue removal and processing affects gene expression
Sandra Ockers, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
March 18, 2016
Androgen receptor splice variant 7 (AR-V7) and drug efficacy in castration-resistant prostate cancer: Biomarker for treatment selection exclusion or inclusion?
Crystal R Leibrand, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
June 2, 2009
VEGF inhibition and metastasis: possible implications for antiangiogenic therapy
Bevin C English, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
June 29, 2010
Genetic variant associated with aggressive not indolent prostate cancer
C Tyler Kirkland, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
November 20, 2010
Prostate cancer genomic signature offers prognostic value
Sarah M Troutman, Douglas K Price, William D Figg
Page
of 11
Search research articles
Search
Showing results (1-10 of 110) with videos related to
Sort By:
Page
of 11
Cell Cycle (Georgetown, Tex.)
|
May 22, 2004
hTert-immortalized endothelial cells: an important new research tool
Douglas K Price, William D Figg
Cancer Biology & Therapy
|
July 16, 2004
Mutations in the EGFR: the importance of genotyping
Douglas K Price, William D Figg
Cancer Biology & Therapy
|
July 10, 2014
Prostate tumor development and androgen receptor function alterations in a new mouse model with ERG overexpression and PTEN inactivation
Anjali Srivastava, Douglas K Price, William D Figg
Anti-Cancer Drugs
|
April 7, 2007
ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer
Haiqing Li, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
May 6, 2016
YAP controls transcriptional elongation through CKD9 recruitment for proximal pause release: "Hippo-thetical", new therapeutic targets?
Fiorina Kyritsi, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
December 19, 2006
DNA microarrays: tissue removal and processing affects gene expression
Sandra Ockers, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
March 18, 2016
Androgen receptor splice variant 7 (AR-V7) and drug efficacy in castration-resistant prostate cancer: Biomarker for treatment selection exclusion or inclusion?
Crystal R Leibrand, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
June 2, 2009
VEGF inhibition and metastasis: possible implications for antiangiogenic therapy
Bevin C English, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
June 29, 2010
Genetic variant associated with aggressive not indolent prostate cancer
C Tyler Kirkland, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
November 20, 2010
Prostate cancer genomic signature offers prognostic value
Sarah M Troutman, Douglas K Price, William D Figg
Page
of 11